QUOIN PHARMACEUTICALS LT-ADR (QNRX)
US74907L3006 - ADR
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | 2.40M | 2.86M | 7.48M | N/A | N/A | |||
| Cash Equivalents | N/A | N/A | N/A | 5.28M | 5.24M | |||
| Marketable Securities | 8.29M | 9.99M | N/A | N/A | N/A | |||
| Receivables | N/A | N/A | N/A | 90.00K | 140.00K | |||
| Other Current Assets | 591.03K | 520.00K | 1.02M | N/A | N/A | |||
| Total Current Assets | 11.29M | 13.37M | 8.50M | 5.37M | 5.38M | |||
| Non-Current Assets | ||||||||
| PPE Net | N/A | N/A | N/A | 600.00K | 670.00K | |||
| Intangibles | 583.33K | 700.00K | 810.00K | N/A | N/A | |||
| Other Non-Current Assets | 300.00K | 380.00K | 50.00K | 100.00K | 100.00K | |||
| Total Non-Current Assets | 883.33K | 1.09M | 860.00K | 730.00K | 800.00K | |||
| TOTAL ASSETS | 12.17M | 14.46M | 9.36M | 6.10M | 6.18M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 600.00K | 600.00K | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | 600.00K | 600.00K | 110.00K | 110.00K | |||
| Accrued Expenses | 2.45M | 2.32M | 2.68M | N/A | N/A | |||
| Accounts Payable | 526.52K | 610.00K | 920.00K | 820.00K | 940.00K | |||
| Other Current Liabilities | N/A | 0.00 | 370.00K | N/A | N/A | |||
| Total Current Liabilities | 3.58M | 3.53M | 4.58M | 930.00K | 1.05M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 2.92M | 3.52M | 4.12M | 120.00K | 200.00K | |||
| Other Non-Current Liabilities | N/A | N/A | N/A | 380.00K | 630.00K | |||
| Total Non-Current Liabilities | 2.92M | 3.52M | 4.12M | 500.00K | 830.00K | |||
| TOTAL LIABILITIES | 6.51M | 7.05M | 8.70M | 1.43M | 1.88M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -46.20M | -37.52M | -28.07M | -31.90M | -24.43M | |||
| Additional Paid In Capital | 51.87M | 47.86M | 31.66M | 39.50M | 31.46M | |||
| Common Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Treasury Stock | 0.00 | -2.93M | -2.93M | -2.94M | -2.73M | |||
| Shares Outstanding | 5.67M | 11.59B | 1.60B | 14.98M | 8.55M | |||
| Tangible Book Value per Share | 5.15 | 0.00 | -0.00 | 1.79 | 2.89 | |||
| Total Shareholders' Equity | 5.66M | 7.41M | 660.00K | 4.67M | 4.30M | |||
| TOTAL LIABILITIES AND EQUITY | 12.17M | 14.46M | 9.36M | 6.10M | 6.18M | |||
| Statistics | ||||||||
| Debt/Equity | 0.62 | 0.56 | 6.24 | 0.03 | 0.05 | |||
| Current Ratio | 3.15 | 3.79 | 1.86 | 5.77 | 5.12 | |||
| Return On Assets (ROA) | -71.38% | -65.35% | -229.27% | -86.23% | -76.38% | |||
| Return On Equity (ROE) | -153.36% | -127.53% | -3251.52% | -112.63% | -109.77% | |||
All data in USD